✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals

Avience Biomedicals Ltd.

AVIENCE

Market Cap
₹0 Cr.
P/E
0.00

Avience Biomedicals Ltd.

Insufficient data

FAQs on Avience Biomedicals Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Avience Biomedicals is 0

View FAQ's On Business

Growth Table

  • Avience Biomedicals Ltd.
  • Morepen Laboratories

Balance Sheet

  • Avience Biomedicals Ltd.
  • Morepen Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Avience Biomedicals Ltd.
  • Morepen Laboratories

Cash Flow

  • Avience Biomedicals Ltd.
  • Morepen Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Avience Biomedicals Ltd.
  • Morepen Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Avience Biomedicals Ltd. Financials

Avience Biomedicals balance sheet is weak and might have solvency issues

The net debt of Avience Biomedicals is decreasing.
Latest net debt of Avience Biomedicals is ₹12.42 Crs as of Mar-25.
This is less than Mar-24 when it was ₹14.51 Crs.

Yes, profit is increasing.
The profit of Avience Biomedicals is ₹7.29 Crs for Mar 2025, ₹2.15 Crs for Mar 2024 and ₹0.78 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Avience Biomedicals latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech